Year archive

Camurus — 2015 filings

All 8 regulatory filings released by Camurus (CAMX) in 2015, sourced directly from the official regulator.

8 Filings

2015 Period

2015 filings (8)

Filing	Released	Lang
Camurus och Braeburn Pharmaceuticals annonserar första dosering i fas 3-effektstudie av långtidsverkande behandling av opiatberoende patienter Regulatory Filings	2015-12-30	Swedish
Braeburn Pharmaceuticals and Camurus enroll first patient in a phase 3 efficacy trial of long-acting treatment for opioid dependence Regulatory Filings	2015-12-30	English
Camurus och Braeburn Pharmaceuticals inleder fas 3-studie av långtidsverkande behandling för opiatberoende Regulatory Filings	2015-12-15	Swedish
Braeburn Pharmaceuticals and Camurus announces start of Phase 3 trial of long-acting buprenorphine treatments for opioid dependence Regulatory Filings	2015-12-15	English
Camurus appoints Chief Commercial Officer Board/Management Information	2015-12-14	English
Camurus utser Chief Commercial Officer Board/Management Information	2015-12-14	Swedish
Major Shareholding Notification 2015 Major Shareholding Notification	2015-12-08	English
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-12-04	English

Filings by year

2026 9 filings
2025 39 filings
2024 37 filings
2023 32 filings
2022 31 filings
2021 43 filings
2020 39 filings
2019 45 filings
2018 41 filings
2017 21 filings
2016 34 filings
2015 8 filings